Table 2.
Study characteristics
| First author (references) | Year | Country | Age (M ± SD) | Number participant | QoL measure | Type of NF/group | Physical function case/control (M ± SD) | Role physical | Bodily pain | Vitality | Mental health | Role emotiona | Social functioning | General health | Family cohesion | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Case | Control | |||||||||||||||
| Page. PZ [19] | 2006 | United States | 43 ± 11.7 | 166 | 154 | SF-36 | 1/Adult |
78 ± 26 84 ± 22 |
70 ± 41 84 ± 22 |
63 ± 27 77 ± 23 |
47 ± 25 59 ± 21 |
63 ± 19 74 ± 23 |
70 ± 38 84 ± 22 |
74 ± 25 84 ± 22 |
55 ± 25 72 ± 23 |
– |
| Kodra. Y [20] | 2009 | Italy | 37.7 ± 122 | 129 | 1909 | SF-36 | 1/Adult |
79 ± 26 86 ± 23 |
75 ± 34 80 ± 35 |
69 ± 27 75 ± 25 |
60 ± 20 63 ± 22 |
64 ± 21 67 ± 20 |
||||
| Merker. VL [21] | 2016 | United States | 13 | 8 | SF-36 | 2/Children |
54/8 52/7 |
53/6 52/3 |
56 50/9 |
53/5 50/3 |
49/9 49/4 |
52/7 51/2 |
49 50/6 |
49/8 51/2 |
||
| Vardarinos. A [22] | 2009 | Greece | 10/1 ± 3 | 43 | 61 | CHQ–PF50 | 2/Children |
94/2 ± 16/7 94/6 ± 7/3 |
91/1 ± 22/8 97 ± 15/2 |
84/4 ± 19/5 94/9 ± 10/3 |
77/7 ± 18 83/1 ± 14/1 |
63/7 ± 19/4 79/8 ± 13/9 |
76/4 ± 22 83/1 ± 15/3 |
|||
| Ostenbrink. R [23] | 2007 | Netherlands | 4 ± 1/5 | 34 | 410 | IT-QOL | 1/children |
88/9 ± 20/3 97/2 ± 9/8 |
86 ± 15/9 83/8 ± 16/8 |
65/5 ± 16/5 79 ± 14/5 |
80/1 ± 22/1 75/3 ± 18/8 |
|||||
| Wolkenstein. P [24] | 2001 | France | 128 | 3656 | SF-36 | 1/adult |
76/8 ± 26/4 84/5 ± 21/1 |
72/8 ± 39/1 81/3 ± 32/2 |
65/3 ± 29/6 73/5 ± 23/7 |
49/7 ± 21/3 60/1 ± 18/1 |
56/4 ± 22 68/5 ± 17/6 |
69/4 ± 39/4 82/2 ± 32/2 |
70/4 ± 25/7 81/6 ± 21/4 |
58/4 ± 23 69/2 ± 18/6 |
||
| Hornigold. RE [25] | 2015 | UK | 44 | 61 | 30 | SF-36 | 2/Adult |
57/4 ± 32/9 87/99 ± 19/65 |
51/5 ± 45/3 87/17 ± 22/01 |
67/3 ± 29 78/8 ± 23/01 |
49/2 ± 27/5 58/04 ± 19/6 |
61/84 ± 26/7 71/92 ± 18/15 |
59/3 ± 45/8 85/75 ± 21/18 |
64/7 ± 33/3 82/77 ± 23/24 |
48/7 ± 31/1 71/06 ± 20/43 |
|
| Krab. LC [26] | 2008 | Netherlands | 12/2 ± 2/5 | 43 | 54 | CHQ | 1/children |
95/7 ± 8/9 96/8 ± 5/4 |
96/1 ± 11/3 96/5 ± 11/6 |
71/4 ± 27/5 78/2 ± 19/5 |
79/8 ± 12/8 78/2 ± 13 |
92 ± 14/4 92/3 ± 16/8 |
72/7 ± 16/2 74/6 ± 15/9 |
75/6 ± 26/7 75/7 ± 23/1 |
||
| Hornigold. RE [27] | 2012 | UK | 41 | 50 | 30 | SF-36 | 2/Adult |
57/4 ± 33/9 84/25 ± 29/19 |
51/5 ± 46/53 83/85 ± 23/89 |
67/3 ± 29/94 81/1 ± 17/05 |
49/2 ± 28/4 62/6 ± 15/38 |
61/84 ± 29/16 74/5 ± 12/02 |
59/3 ± 47/23 82/65 ± 13/28 |
64/7 ± 33/91 88/2 ± 11/74 |
48/7 ± 31/74 73/05 ± 14/4 |
|
| Merker. VL [28] | 2014 | United state |
38/7 ± 14/5 39/7 ± 29/7 |
142/53 | 50/50 | SF-36 | 1,2/Adult |
49/2 46/1 49/2 49/2 |
48 44/5 46/6 46/6 |
50/9 50/3 46/1 46/1 |
50/3 47/8 49/1 49/1 |
46/5 48 49/2 49/2 |
46/2 47/4 47/9 47/9 |
48/7 45 48/1 48/1 |
48/6 42/8 47/5 47/5 |
|